EPO and asthma: On the contrary, CPX increased the expression of MHCII, CD40L, Il-13, eotaxin (Ccl11), Mbp, and Epo on late reaction (Fig. 6B); therefore, CPX did not significantly decrease the entire asthma pathway (Fig. 6C).